🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/07/2007 11,80 11,96 11,72 11,82 -0,51% 2,03% 461.300
13/07/2007 11,91 12,00 11,84 11,88 -0,67% 1,34% 381.700
12/07/2007 12,07 12,14 11,88 11,96 -0,83% 2,15% 291.700
11/07/2007 11,78 12,17 11,77 12,06 +2,12% 3,40% 411.100
10/07/2007 12,22 12,22 11,79 11,81 -3,51% 3,52% 396.800
09/07/2007 11,71 12,34 11,71 12,24 +4,53% 5,38% 571.100
06/07/2007 11,61 11,75 11,55 11,71 +0,69% 1,72% 311.500
05/07/2007 11,51 11,65 11,21 11,63 +0,87% 3,82% 410.800
03/07/2007 11,47 11,58 11,27 11,53 +0,52% 2,70% 183.500
02/07/2007 11,30 11,50 11,22 11,47 +2,14% 2,48% 352.300
29/06/2007 11,53 11,58 11,22 11,23 -2,43% 3,12% 412.500
28/06/2007 11,67 11,67 11,43 11,51 -1,12% 2,06% 288.400
27/06/2007 11,38 11,71 11,35 11,64 +1,31% 3,16% 351.700
26/06/2007 11,74 11,81 11,39 11,49 -1,79% 3,58% 874.000
25/06/2007 11,70 11,94 11,59 11,70 -0,93% 2,99% 957.100
22/06/2007 12,02 12,19 11,64 11,81 -2,07% 4,58% 1.065.000
21/06/2007 12,33 12,33 12,01 12,06 -2,66% 2,60% 633.700
20/06/2007 12,60 12,68 12,35 12,39 -2,82% 2,62% 578.800
19/06/2007 12,34 12,76 12,21 12,75 +3,91% 4,46% 736.400
18/06/2007 12,51 12,51 12,03 12,27 -1,29% 3,84% 529.100
15/06/2007 12,80 12,80 12,37 12,43 -1,43% 3,36% 857.000
14/06/2007 12,40 12,78 12,37 12,61 +1,45% 3,31% 573.200
13/06/2007 12,81 12,93 12,37 12,43 -1,51% 4,37% 1.001.300
12/06/2007 12,59 13,12 12,46 12,62 +0,00% 5,24% 792.200
11/06/2007 12,46 12,74 12,39 12,62 +1,12% 2,81% 355.300
08/06/2007 12,21 12,57 12,16 12,48 +1,79% 3,36% 279.600
07/06/2007 12,62 12,65 12,16 12,26 -3,16% 3,88% 480.300
06/06/2007 12,30 12,80 12,30 12,66 +2,10% 4,07% 731.500
05/06/2007 12,26 12,48 12,25 12,40 +0,49% 1,88% 444.000
04/06/2007 12,35 12,64 12,24 12,34 -0,24% 3,24% 792.900